Showing results (11-20 of 2,507) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2021
Palliative Radiotherapy for Diffuse Large B-cell LymphomaChristopher M Wright, Antony I Koroulakis, Jonathan A Baron, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 1, 2020
Outcome and Prognostic Features in Pediatric Acute Megakaryoblastic Leukemia Without Down Syndrome: A Retrospective Study in ChinaYu Wang, Aidong Lu, Yueping Jia, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 8, 2020
The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient TransplantationMassimo Martino, Annalisa Pitino, Giovanni Tripepi, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2020
Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value-A Multicenter Study From South IndiaShashidhar V Karpurmath, Arun Seshachalam, Kalaiselvi Selvaraj, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 11, 2020
Efficacy of Single Low-Dose Rasburicase in Management of Tumor Lysis Syndrome in Leukemia and Lymphoma PatientsGopila Gupta, Tulika Seth, Vikas Garg, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2022
Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech Registry DataVladimir Maisnar, Ludek Pour, Ivan Spicka, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 22, 2021
Prognosis and Outcome of Fit Patients with Acute Myeloid Leukemia in KuwaitSalem H Alshemmari, Ramesh Pandita, Mohan Ram, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 23, 2021
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) StudySarah Lawless, Giulia Sbianchi, Curly Morris, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 2, 2023
Efficacy and Safety of Blinatumomab for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Systemic Review and Meta-AnalysisHeng Liu, Rui Xi, Dongfeng Mao, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2023
Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene FusionYumeng Zhang, Lynn Nguyen, Chuanyi M Lu, et al.
Pageof 251